SEC Company Response from HEMOBIOTECH INC (CIK 0001301348) — May 13, 2005
HEMOBIOTECH INC (CIK 0001301348)
Date: May 13, 2005 · CIK: 0001301348 · Accession: 0000930413-05-003582
AI Filing Summary & Sentiment
File numbers found in text: 333-122097
Letter
Re: Hemobiotech, Inc. Registration Statement on Form SB-2 (Registration No. 333-122097) -----------------------------------------------------------------
May 13, 2005
VIA FACSIMILE (202) 942-9585 AND EDGAR
Securities and Exchange Commission Judiciary Plaza 450 Fifth Street, N.W. Washington, D.C. 20549-0404 Attention: Mr. Daniel Greenspan
Ladies and Gentlemen:
On behalf of Hemobiotech, Inc., a Delaware corporation (the "Company"), we are transmitting herewith the Company's request for acceleration of the effective date of the above-referenced Registration Statement to 3:00 p.m., New York City time, on Friday, May 13, 2005, or as soon as practicable thereafter.
Please advise the undersigned or Robert Cohen of our office of the effective date of the Registration Statement. You can reach the undersigned at (212) 801-9362 or Robert Cohen at (212) 801-6907.
Very truly yours,
/s/ Anthony J. Marsico ---------------------- Anthony J. Marsico
cc: Dr. Arthur P. Bollon Robert Cohen, Esq. Marlene M. Markard, Esq.
<PAGE>
HEMOBIOTECH, INC. 14221 Dallas Parkway Suite 1500 Dallas, Texas 75254
May 13, 2005
VIA FACSIMILE (202) 942-9585 AND EDGAR
Securities and Exchange Commission Judiciary Plaza 450 Fifth Street, N.W. Washington, D.C. 20549-0404 Attention: Mr. Daniel Greenspan
Re: Hemobiotech, Inc. Registration Statement on Form SB-2 (Registration No. 333-122097) -----------------------------------------------------------------
Ladies and Gentlemen:
We hereby request that the effective date of the above-referenced Registration Statement be accelerated so that it will become effective at 3:00 p.m., New York City time, on Friday, May 13, 2005, or as soon as practicable thereafter.
Very truly yours,
HEMOBIOTECH, INC.
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
May 13, 2005
VIA FACSIMILE (202) 942-9585 AND EDGAR
Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549-0404
Attention: Mr. Daniel Greenspan
Re: Hemobiotech, Inc.
Registration Statement on Form SB-2 (Registration No. 333-122097)
-----------------------------------------------------------------
Ladies and Gentlemen:
On behalf of Hemobiotech, Inc., a Delaware corporation (the "Company"),
we are transmitting herewith the Company's request for acceleration of the
effective date of the above-referenced Registration Statement to 3:00 p.m., New
York City time, on Friday, May 13, 2005, or as soon as practicable thereafter.
Please advise the undersigned or Robert Cohen of our office of the
effective date of the Registration Statement. You can reach the undersigned at
(212) 801-9362 or Robert Cohen at (212) 801-6907.
Very truly yours,
/s/ Anthony J. Marsico
----------------------
Anthony J. Marsico
cc: Dr. Arthur P. Bollon
Robert Cohen, Esq.
Marlene M. Markard, Esq.
<PAGE>
HEMOBIOTECH, INC.
14221 Dallas Parkway
Suite 1500
Dallas, Texas 75254
May 13, 2005
VIA FACSIMILE (202) 942-9585 AND EDGAR
Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549-0404
Attention: Mr. Daniel Greenspan
Re: Hemobiotech, Inc.
Registration Statement on Form SB-2 (Registration No. 333-122097)
-----------------------------------------------------------------
Ladies and Gentlemen:
We hereby request that the effective date of the above-referenced
Registration Statement be accelerated so that it will become effective at 3:00
p.m., New York City time, on Friday, May 13, 2005, or as soon as practicable
thereafter.
Very truly yours,
HEMOBIOTECH, INC.
By: /s/ Arthur P. Bollon
--------------------------------------
Arthur P. Bollon
President, Chief Executive Officer and
Chairman
</TEXT>
</DOCUMENT>